GlaxoSmithKline submits regulatory application for UMEC/VI

A.B. | ShareCast | 18 Dec, 2012 12:05 - Updated: 12:58 | | |

needle

Pharmaceutical companies GlaxoSmithKline (GSK) and Theravance have submitted a regulatory application in the US for UMEC/VI medicine, used to treat chronic obstructive pulmonary disease (COPD).

UMEC/VI is an investigational once-daily LAMA/LABA combination medicine. It includes properties, umeclidinium bromide --- a long-acting muscarinic antagonist (LAMA)--- and vilanterol, a long-acting beta2 agonist which is administered using the Ellipta inhaler.

The application proposes the proprietary name Anora Ellipta and has been submitted to the US Food and Drug Administration for the long-term once-daily maintenance bronchodilator treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema.

Applications for UMEC/VI are also planned in the European Union and in other countries next year.

FSTE 100 company GSK is a leading research-based pharmaceutical and healthcare company.

Theravance is a biopharmaceutical company which collaborates with a number of pharmaceutical organisations.

RD

More news

19:19 Sunday newspaper round-up: Lloyds, Marks&Spencer, Oil explorers

Lloyds Banking Group is considering moving its legal home to England from Scotland even after the Scots voted against leaving the UK, the Mail on Sunday reported. Lloyds had said it would move if Scotland voted to leave the union but has only said it would keep "a significant presence" in Scotland after a no vote. More devoloution of powers to Scotland could lead to a different Scottish tax rate or tax regime. The bank will also have to make changes to its legal structure because of requirements to split retail and investment banking.

15:53 Sunday share tips: GlaxoSmithKline, African Minerals, WANdisco

Buy shares of GlaxoSmithKline, Questor said in the Sunday Telegraph. China's £297m fine against GSK for corruption is manageable and has lifted the cloud that hung over the company. The shares have underperformed the wider market and are trading on 15.3 times forecast earnings compared with 22 times for the FTSE 350 pharma sector. With US and UK investigations into alleged corruption continuing, GSK is not out of the woods yet but it is not in those governments' interests to disrupt GSK's drug programmes and trigger job cuts so the shares should recover.

19 Sep US close: Stocks mostly lower as outlook for economy slows

US stocks ended the session mostly lower after a report showed the outlook for the US economy slowed.

19 Sep Market overview: Alex Salmond may resign, reports say

1630:Close UK stocks have ended the session slightly higher despite the victory of the no camp in the Scottish referendum.

19 Sep Barclays expects full-blown QE from ECB in Q1 2015

The European Central Bank (ECB) is expected to extend its new asset purchase programme by adding central government bonds (EGBs) by the first quarter of 2015, according to Barclays' analysts.

19 Sep France launches first airstrikes against ISIS

France has launched its first airstrikes in the fight against Islamic State in Iraq

19 Sep Apple sees a successful first day of iPhone sales after four million pre-orders

The new iPhone 6 and 6 plus went on sale on Friday in several cities around the world, after the technology giant Apple unveiled the much anticipated smartphones earlier this month.

19 Sep London close: FTSE ends with modest gains after Scottish vote, Salmond quits

London-listed stocks ended the final session of the week with decent gains, although the final figure was notably lower than the level seen earlier in the day following the Scottish referendum result.

19 Sep Europe close: Stocks gain after Scotland votes against independence from UK

European stocks gained Friday after Scotland rejected independence from the UK in a referendum.

19 Sep Alibaba shares soar in stock market debut - UPDATE

The Alibaba Group started trading at $92.70 per share on the New York Stock Exchange (NYSE), sharply higher than the $68 per share at which it had been priced.

Advertising

HIGHLIGHTS

Sunday newspaper round-up: Lloyds, Marks&Spencer, Oil explorers

Lloyds Banking Group is considering moving its legal home to England from Scotland.

VIDEOS

The first resistance level now changes from 1.3220 to 1.3160
REGISTER NOW!